CD44 and neoplasm: In our analysis, we observed that the chemo-naïve basal tumor samples had high CD44 and low CD24 expression (CD44+/CD24−/low phenotype), which could be interpreted as BCSC-enriched, consistent with previous studies on chemoresistant cohorts [18].